Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oncolytics Biotech Q3 EPS $(0.09) Beats $(0.12) Estimate

Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.12) by 25 percent. This is a 25 percent increase over losses of $(0.12) per share from the

byBenzinga Newsdesk

November 5, 2021

1 minute read

Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.12) by 25 percent. This is a 25 percent increase over losses of $(0.12) per share from the same period last year.